Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population-Reference-Cited by-同舟云学术

Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population

Published:2016-10-17 Issue:10 Volume:11 Page:e0164491
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wang Zhen,Xia Rong-Hui,Ye Dong-Xia,Li Jiang

Funder

National Natural Science Foundation of China

Doctoral Scientific Fund Project of the Ministry of Education of China

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review;AR Kreimer;Cancer Epidemiol Biomarkers Prev,2005

2. Human papillomavirus and rising oropharyngeal cancer incidence in the United States;AK Chaturvedi;J Clin Oncol,2011

3. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers;ML Gillison;J Natl Cancer Inst,2000

4. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas;JP Klussmann;Cancer,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential tumor immune microenvironment coupled with tumor progression or tumor eradication in HPV-antigen expressing squamous cell carcinoma (SCC) models;Frontiers in Immunology;2024-07-11

2. Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and host-intrinsic factors;Frontiers in Oncology;2022-10-18

3. Long Intergenic Non-Coding RNAs in HNSCC: From “Junk DNA” to Important Prognostic Factor;Cancers;2021-06-12

4. Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients;Human Vaccines & Immunotherapeutics;2021-03-09

5. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance;OncoTargets and Therapy;2021-02